Investigational COVID-19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction

---
identifier: "/us/fr/2020-22142"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Investigational COVID-19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2020-22142"
section_name: "Investigational COVID-19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction"
positive_law: false
currency: "2020-10-07"
last_updated: "2020-10-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-22142"
document_type: "notice"
publication_date: "2020-10-07"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "85 FR 63277"
fr_volume: 85
docket_ids:
  - "Docket No. FDA-2020-D-1137"
fr_action: "Notice; correction."
---


#  Investigational COVID-19 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that published in the *Federal Register* of September 21, 2020. The document announced the withdrawal of a final guidance for industry entitled “Investigational COVID-19 Convalescent Plasma,” which was issued in April 2020 and updated in May 2020. FDA withdrew the guidance because the Agency issued a new guidance for industry of the same title. The document was published with the incorrect docket number for the guidance for industry that was withdrawn. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Shruti Modi, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-402-7911.

**SUPPLEMENTARY INFORMATION:**

**Correction**

In the *Federal Register* of September 18, 2020 (85 FR 593120), appearing on page 59320 in FR Doc. 2020-20801, the following correction is made:

On page 59320, in the third column, the Docket No. “FDA-2020-D-1825” is corrected to read “FDA-2020-D-1137.”

Dated: October 1, 2020.

Lauren K. Roth,

Acting Principal Associate Commissioner for Policy.